AKLIEF 0.005 % Topical Cream
- RxCUI
- 2205647
- RxNorm name
- AKLIEF 0.005 % Topical Cream
- Display name
- AKLIEF 0.005 % Topical Cream
- Full name
- AKLIEF 0.005 % Topical Cream
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:01
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| AKLIEF | TRIFAROTENE | Galderma Laboratories, L.P. | 62d910db-85a6-4696-b69b-4bd2f3080cfc | 2024-09-16 | Warnings, Adverse reactions | 2205647 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 62d910db-85a6-4696-b69b-4bd2f3080cfc | AKLIEF 0.005 % Topical Cream [PSN] · trifarotene 0.05 MG/ML Topical Cream [Aklief] [SBD] · Aklief 0.005 % Topical Cream [SY] · Aklief 0.05 MG/ML Topical Cream [SY] | 4 | 7 | These highlights do not include all the information needed to use AKLIEF ® Cream safely and effectively. See full prescribing information for AKLIEF Cream. AKLIEF(trifarotene) cream, for topical use Initial U.S. Approval: 2019 | 20240916 |